Cardiology and COVID-19: do We have Sufficient information?

Garg, Naveen; McClafferty, Brendan; Ramgobin, Devyani; Golamari, Reshma; Jain, Rahul; Jain, Rohit

doi:10.2217/fca-2020-0126

Cited by 4 publications

(6 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[43][44][45][46] Additionally, multiple reports have suggested that patients with underlying cardiovascular comorbidities such as heart failure are at higher risk of severe disease and mortality due to COVID-19. 44,[47][48][49][50] Collectively, the rescreening of patients with worsening cardiovascular disease was indeed necessary. For patients attending the Department of Internal Medicine, the higher rescreening rate in the Division of Infectious Diseases may be because approximately half of the quarantined patients belonged to that division, while the lower rescreening rate in the Division of Hematology and Oncology could possibly be explained by the fact that around three-quarters of the cases were repeatedly included due to recurrent fever caused by the underlying disease or anticancer therapy.…”

mentioning

confidence: 99%

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Hsu¹,

Liu²,

Tseng³

et al. 2021

JMDH

View full text Add to dashboard Cite

Purpose:The COVID-19 pandemic poses a serious threat to healthcare workers and hospitalized patients. Early detection of COVID-19 cases is essential to control the spread in healthcare facilities. However, real-world data on the screening criteria for hospitalized patients remain scarce. We aimed to explore whether patients with negative results of prehospital screening for COVID-19 should be rescreened after admission in a low-prevalence (less than 3% of the world average) setting. Patients and Methods:We retrospectively included patients in central Taiwan who were negative at the first screening but were newly diagnosed with pneumonia or had a body temperature above 38 degrees Celsius during their hospitalization. Each patient might be included as an eligible case several times, and the proportions of cases who were rescreened for COVID-19 and those diagnosed with COVID-19 were calculated. A logistic regression model was constructed to identify factors associated with rescreening. Reverse transcriptionpolymerase chain reaction tests were used to confirm the diagnosis of COVID-19. Results: A total of 3549 cases eligible for COVID-19 rescreening were included. There were 242 cases (6.8%) who received rescreening. In the multivariable analysis, cases aged 75 years or older, those with potential exposure to SARS-CoV-2, or patients visiting specific departments, such as the Cardiovascular Center and Department of Neurology, were more likely to be rescreened. None was diagnosed with COVID-19 after rescreening. There was no known cluster infection outbreak in the hospital or in the local community during the study period and in the following two months. Conclusion:In Taiwan, a country with a low COVID-19 prevalence, it was deemed safe to rescreen only high-risk hospitalized patients. This strategy was effective and reduced unnecessary costs.

show abstract

mentioning

confidence: 99%

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Hsu¹,

Liu²,

Tseng³

et al. 2021

JMDH

View full text Add to dashboard Cite

show abstract

“…Once the virus attaches, this leads to myocardial infarction. Angiotensin-converting enzyme-2 dependent myocardial infarction leads to the decreased angiotensin-converting enzyme-2 expression [ 16 ]. The infection causes macrophage infiltration in the heart leading to myocarditis [ 17 ].…”

Section: Pathophysiologymentioning

confidence: 99%

“…Signs of myocardial injury can be seen with elevated cardiac troponin markers, abnormal ECG findings and magnetic resonance-based imaging (Fig. 1 ) [ 16 , 20 ].…”

Section: Pathophysiologymentioning

confidence: 99%

See 1 more Smart Citation

Possible Long-Term Cardiovascular Effects of COVID-19

Lugo

Nizami

Haniff

et al. 2023

CCR

View full text Add to dashboard Cite

Coronavirus Disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become a worldwide pandemic. Since 2019, the virus has mutated into multiple variants that have made it harder to eradicate and have increased the rate of infection. This virus can affect the structure and the function of the heart and can lead to cardiovascular symptoms that can have long-lasting effects despite recovery from COVID-19. These symptoms include chest pain, palpitations, fatigue, shortness of breath, rapid heartbeat, arrhythmias, cough or hypotension. These symptoms may persist due to myocardial injury, cardiac inflammation, or systemic damage that may have been caused during infection. If these symptoms persist, the patient should visit their cardiologist for diagnosis and treatment plan for any type of cardiovascular disease that may have developed Post-COVID 19.

show abstract

“…The lockdown has increased the social anxiety in people as they were totally away from each other during those days when people with social anxiety disorder come into public places, they start feeling they have lost their comfortable zone and thus try to avoid going into public places 10 . The symptoms of social anxiety disorder manifest physically and psychologically ranging from symptoms of social anxiety including nausea, excessive sweating, tachycardia, shivering, etc 11 .…”

Section: Introductionmentioning

confidence: 99%

Comparative Assessment of Trends of Social Anxiety and Social Avoidance during First and Second Wave of Covid-19

Sikandar¹,

Bakar²,

Aleem³

et al. 2022

PJMHS

View full text Add to dashboard Cite

Background: Corona virus disease 2019 (COVID-19) was first reported in China and became the global pandemic. This pandemic has proven fatal for the world and lasts drastic effects on the whole world. To combat with this hilarious pandemic, the whole world has adopted the strategy of social distancing and precautionary measures. Aim: To compare trends of social anxiety and avoidance during covid wave 1 and covid wave 2. Methodology: A cross-sectional study was conducted at Central Park Medical College from October 2020 and January 2021. To assess social avoidance and anxiety LIEBOWITZ Social Anxiety and avoidance Scale was employed. Paired sample t test and correlation was used to compare mean differences. A p value less than 0.05 were considered significant. Results: There was a reduction of score of social anxiety from covid wave 1 and wave 2 (26.73±4.65. 17.86±3.81) with p value of .001 and similarly there was a reduction of score of social avoidance (25.31±0.597 v/s 15.±0.3390) as well from wave 1 to wave 2 with p value of .001 Conclusion: There is a continuous decline in social avoidance and social anxiety which can cause an increase in covid 19 infection rate in order to combat that there’s need of prompt vaccination along with the precautionary measures to combat covid pandemic. MeSH Words: Covid-19, Social anxiety, social avoidance, covid wave.

show abstract

Cardiology and COVID-19: do We have Sufficient information?

Cited by 4 publications

References 37 publications

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Possible Long-Term Cardiovascular Effects of COVID-19

Comparative Assessment of Trends of Social Anxiety and Social Avoidance during First and Second Wave of Covid-19

Contact Info

Product

Resources

About